Mutations in CHCHD2 have also been associated with the aggregation and oligomerization of α-synuclein in the postmortem brain tissues of people with PD and iPSC-derived dopaminergic neurons [45]. This evidence concerns the gene CHCHD2 and Parkinson disease.